Brentuximab Vedotin-induced Tumour Lysis Syndrome in Mycosis Fungoides: A Case Report
Abstract is missing (Short communication)
Saved in:
Main Authors: | Berenika Olszewska (Author), Anna Zaryczańska (Author), Roman J. Nowicki (Author), Małgorzata Sokołowska-Wojdyło (Author) |
---|---|
Format: | Book |
Published: |
Medical Journals Sweden,
2024-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Brentuximab vedotin treatment for mycosis fungoides with CD30+ large‐cell transformation in the early stage
by: Shujiro Hayashi, et al.
Published: (2023) -
2024 update of the article: Primary cutaneous lymphomas. Diagnostic and therapeutic guidelines of the Polish Dermatological Society (PTD) and Polish Lymphoma Research Group (PLRG)
by: Małgorzata Sokołowska-Wojdyło, et al.
Published: (2024) -
[Translated article] Advanced-Stage CD30+ Mycosis Fungoides Treated With Brentuximab
by: C. Vico-Alonso, et al.
Published: (2022) -
Sézary syndrome preceded by mycosis fungoides and complicated by tumor lysis syndrome and macrophage activation syndrome
by: Asmae Abdelmouttalib, et al.
Published: (2022) -
Brentuximab vedotin for relapsed or refractory Hodgkin’s lymphoma
by: Chen R, et al.
Published: (2015)